0001493152-24-023766.txt : 20240613
0001493152-24-023766.hdr.sgml : 20240613
20240613195946
ACCESSION NUMBER: 0001493152-24-023766
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240611
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brams Matthew
CENTRAL INDEX KEY: 0001884361
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40874
FILM NUMBER: 241042716
MAIL ADDRESS:
STREET 1: C/O CINGULATE INC.
STREET 2: 1901 W. 47TH PLACE
CITY: KANSAS CITY
STATE: KS
ZIP: 66205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cingulate Inc.
CENTRAL INDEX KEY: 0001862150
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863825535
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1901 W. 47TH PLACE
CITY: KANSAS CITY
STATE: KS
ZIP: 66205
BUSINESS PHONE: (913) 942-2300
MAIL ADDRESS:
STREET 1: 1901 W. 47TH PLACE
CITY: KANSAS CITY
STATE: KS
ZIP: 66205
4
1
ownership.xml
X0508
4
2024-06-11
0
0001862150
Cingulate Inc.
CING
0001884361
Brams Matthew
1901 W. 47TH PLACE
KANSAS CITY
KS
66205
0
1
0
0
EVP and Chief Medical Officer
0
Stock Option (right to Buy)
1.18
2024-06-11
4
A
0
63324
0
A
2034-03-04
Common Stock
63324
63324
D
The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the "Amendment"). Cingulate's stockholders approved the Amendment on June 11, 2024.
The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date.
/s/ Shane J. Schaffer, Attorney-in-Fact
2024-06-13